Healthcare Triangle Acquires Teyame AI to Enhance AI Capabilities and Revenue Growth

Healthcare Triangle Expands AI Capabilities with Acquisition of Teyame AI

Healthcare Triangle, Inc. (Nasdaq: HCTI), a frontrunner in digital transformation for healthcare and life sciences, announces a strategic acquisition of Teyame AI LLC, a company registered in St Kitts and Nevis. This move includes the purchase of Teyame 360 SL and Datono Mediacion SL—two Spain-based firms that specialize in AI-enhanced omnichannel customer experience solutions. The acquisition, valued at approximately $50 million, is set to close on January 29, 2026, pending shareholder approval, with an effective date of January 1, 2026. This transaction marks a significant step for HCTI as it aims to enhance its operational capabilities and strengthen its footprint in the evolving healthcare technology landscape.

The acquisition is projected to generate an additional $32 million in annual revenue and approximately $3.6 million in EBITDA for fiscal year 2025. HCTI views this development as a crucial transition from a traditional healthcare IT provider to a comprehensive digital innovator. David Ayanoglou, HCTI's Chief Financial Officer, emphasizes that incorporating Teyame’s AI expertise will fundamentally transform the company’s operations, enabling real-world applications of AI within its existing framework. The merger not only promises financial benefits but also positions HCTI to offer more sophisticated solutions tailored to the needs of healthcare providers and patients.

Sujatha Ramesh, HCTI's Chief Operating Officer, highlights the transformative potential of this acquisition, envisioning a next-generation intelligent ecosystem that improves engagement and care management. This strategic move aligns with HCTI's broader objectives, which focus on AI-driven healthcare innovation and expanding its SaaS offerings into high-growth international markets, particularly in Europe and Latin America. By synergizing HCTI’s healthcare technology expertise with Teyame's advanced AI capabilities, the company aims to deliver integrated solutions that significantly enhance both patient and provider experiences, solidifying its position as a leader in the digital healthcare space.

In addition to the anticipated financial uplift, this acquisition serves as a testament to HCTI's commitment to innovation in healthcare. The integration of AI into healthcare solutions is increasingly crucial as the industry shifts towards data-driven decision-making and personalized patient care. By leveraging Teyame's expertise, HCTI not only enhances its service offerings but also reinforces its mission to improve healthcare accessibility and efficiency through technology.

This acquisition reflects HCTI’s proactive approach to navigating the complexities of the healthcare landscape, ensuring that it remains at the forefront of digital transformation. As the company prepares for this transition, the focus remains on creating holistic solutions that address the evolving needs of the healthcare ecosystem.